Actively Recruiting
Comparing Peripheral Blood Stem Cells Alone Versus Bone Marrow Plus Peripheral Blood Stem Cells for Haploidentical Transplantation in Severe Aplastic Anemia
Led by Peking University People's Hospital · Updated on 2026-09-16
180
Participants Needed
1
Research Sites
141 weeks
Total Duration
AI-Summary
What This Trial Is About
Severe aplastic anemia is a serious bone marrow failure disorder that can be life-threatening. Researchers are studying different sources of stem cell grafts for haploidentical hematopoietic stem cell transplantation in patients aged 18 to 40 years with severe or very severe aplastic anemia. This trial aims to compare the effectiveness and safety of using peripheral blood stem cells alone versus a combination of bone marrow and peripheral blood stem cells as graft sources. The study is randomized, open-label, and designed to assess if the simpler peripheral blood stem cell method is not worse than the traditional combined graft in terms of graft-versus-host disease risk. Participants are randomly assigned to one of two groups one group receives granulocyte colony-stimulating factor G-CSF-primed peripheral blood stem cells alone, collected by apheresis after donor mobilization the other group receives G-CSF-primed bone marrow plus peripheral blood stem cells, with donors undergoing both bone marrow harvest and peripheral blood stem cell collection. All participants receive a conditioning regimen and graft-versus-host disease prevention treatment according to the protocol. Donors are mobilized with G-CSF before collection. Throughout the study, participants are monitored for the development of acute graft-versus-host disease within 100 days after transplantation, which is the primary outcome. Researchers also track engraftment success, chronic graft-versus-host disease, infections, immune system recovery, survival, and donor safety. The trial begins with screening and informed consent, followed by transplantation and post-transplant monitoring, with the study expected to complete by the end of 2029.
CONDITIONS
Brief Title
Peripheral Blood Versus Bone Marrow Plus Peripheral Blood Grafts for Haploidentical Transplantation in Severe Aplastic Anemia
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here